This Week in Psychedelics - 9.24.21

Cannabis

• Switzerland’s Zurich to Begin Recreational Cannabis Trial in 2022 (High Times)

• U.S. House Approves SAFE Banking Act as Part of Military Spending Bill in Historic Vote (High Times)

• Green Party in Finland Calls for End of Prohibition (High Times)

• This company is smuggling tons of legal cannabis into streets, whistleblower alleges (Leafly)

• California State Fair Will Host Marijuana Competition For The First Time At 2022 Event, Officials Announce (Marijuana Moment)

• Connecticut: Qualified Patients Can Begin Home Cultivating Cannabis Next Week (NORML)

• Rhode Island Lawmakers Are ‘Very Close’ On Marijuana Legalization Deal Ahead Of Possible Special Session, Top Senator Says (Marijuana Moment)

• Lessons the Psychedelics Industry Can Learn From the Cannabis Market Bubble (Lucid News)

• Pennsylvania Senators Discuss Bill To Provide DUI Protections For Medical Marijuana Patients (Marijuana Moment)

• VA sending mixed messages for vets about cannabis use to treat PTSD (Arizona Mirror)

• Delaware: Governor Signs Measure Amending Cannabis Penalties for Minors (NORML)

• FBI Clarifies That Using Marijuana More Than 24 Times Disqualifies Would-Be Agents (Marijuana Moment)

• Former Massachusetts Mayor Sentenced for Extortion (High Times)

• Controlling cannabis and the classification of Delta-8 THC (Reuters)

• Eaze launches California program to bring free medical cannabis to low-income patients (Greenway Magazine)

• Mississippi Lawmakers Reach Deal On Medical Marijuana Legalization, Plan To Request Special Session (Marijuana Moment)

• For Chronic Pain Sufferers, Cannabis "May Be a Source of Hope" (Green Entrepreneur)

• Full-Page Washington Post Ad Calls For Marijuana Prisoner’s Freedom While Celebs Make Money In Industry (Marijuana Moment)

• Can Cannabis Help Your Gut? (TIME)

• Florida Marijuana Activists File New Legalization Initiative For 2022 Ballot Following Supreme Court Defeats (Marijuana Moment)

• Oklahoma Activists Finalize Language For Two 2022 Marijuana Ballot Initiatives (Marijuana Moment)

• Nebraska Cannabis Association launches as state's first lobbying group for marijuana-based businesses (York News-Times)

Magic Mushrooms

• Psilocybin Study for Tobacco Gets Federal Funding (Truffle Report)

• Thousands attend first-ever psychedelic shroom festival in Ann Arbor (MLive.com)

• Canadian Coalition Submits Draft for Legal Psilocybin Therapy (Truffle Report)

• Happy Global Magic Mushroom Day (9/20) for Psilocybin Fans (CelebStoner)

• Nine Perfect Strangers's Portrayal of Psilocybin Could Derail Progress in Researching Psychedelic Use for Mental Health (Teen Vogue)

• Shroom Delivery is Now a Thing (DoubleBlind)

• Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac (Newsweek)

• Former GOP Congresswoman Touts Psilocybin As Treatment For Alcoholism (Marijuana Moment)

• Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1 (Psilocybin Alpha)

• Amanita muscaria – A Fresh Look at An Iconic Mushroom (Psychedelic Science Review)

• The 25 Best U.S. Counties for Mushroom Foragers (moveBuddha)

• MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration (Psilocybin Alpha)

• Eversio Wellness Harvests Its First Legally Grown Psychoactive Mushrooms (Yahoo! Finance)

MDMA

• Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial College London (Psilocybin Alpha)

DMT

• Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy (Psilocybin Alpha)

5-MeO-DMT

• I Wanted Ego Death. This Powerful Psychedelic Gave It To Me. (BuzzFeed News)

• Lexston Initiates Research and Development Project Using Psychedelic Compound 5-Me0-DMT (TheNewswire)

Mescaline

• Mescaline, Veganism, and Schopenhauer’s Philosophy (Sam Woolfe)

Iboga

• DemeRx Doses First Subject in Phase 1/2a Study of DMX-1002 (Ibogaine) in Opioid Use Disorder (Psilocybin Alpha)

Salvia Divinorum

• Salvia Divinorum and Kratom Combination – What You Must Know About It (IRN Post)

Novel Psychoactive Substances

• Are Prodrugs the Next Wave of Psychedelic Drug Development? (Psychedelic Science Review)

• Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and Improved Safety Profile for its 5-MeO-DMT-Inspired Drug Candidate, MSP-4018 (Psilocybin Alpha)

• Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in Eating Disorders (Psilocybin Alpha)

• Clearmind Medicine Partners with The Hebrew University to Develop Novel Psychedelic Drug (Yahoo! Finance)

• Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data (Psilocybin Alpha)

Synthetic Cannabinoids

• Spice is significantly more harmful than marijuana (International Business Times)

• New Study Comparing Plant-Derived and Synthetic CBD Efficacy Opens Door to Exciting Medical Uses of Cannabidiol (Yahoo! Finance)

Nitrous Oxide

• TikTok Is Hosting Ads for ‘Whipped Cream’. But It’s Actually Nitrous Oxide (VICE)

Ketamine

• Delic signs US$10 million merger deal to become top psychedelic wellness chain in the U.S. (Canadian Lawyer)

• Turning Everyday Therapist Offices into Ketamine Clinics (Lucid News)

• Statistical model defines ketamine anesthesia’s effects on the brain (MIT News)

• Is A Ketamine Infusion Covered By Insurance? (Healing Maps)

Miscellaneous

• Companies are Getting Rid of Drug Tests Because They Can’t Find Enough Workers (VICE)

• Class A drug possession ‘effectively decriminalised’ in Scotland (The Times)

• Hamilton Morris Hired by Psilocybin Startup COMPASS Pathways, Ends "Hamilton's Pharmacopeia" On Vice (Psymposia)

• Italian Advocates Collect 500,000 Signatures for Decriminalization of Cannabis and Psychoactive Substances (High Times)

• Psychedelics Are a Billion-Dollar Business, and No One Can Agree Who Should Control It (VICE)

• Meet Microdosing TikTok—And Why the Community Matters (Psychedelics Today)

• More Michigan Cities Look to Decriminalize Psychedelics (Truffle Report)

• The Michigan Poison and Drug Information Center issues notification about effects and risks of using psychedelic substances (Today@Wayne)

• Criticism of Awakn Treatment Model as Second Clinic Opens for Treating Addiction (TalkingDrugs)

• Psychedelic Patents: Nature, IP Law, & Exclusion (Truffle Report)

• How To Come Down From A High: Navigating the Downslope of a Trip (DoubleBlind)

• Armed With Two Patents, Psycheceutical Plans To Transform Psychedelic Drug Delivery (Forbes)

• Psychedelic Water founder looks to new legal era for powerful drugs (The Washington Times)

• Mycrodose Therapeutics Successfully Completes Oversubscribed Private Placement to Expand Existing Patent Portfolio of Breakthrough Advanced Drug Delivery Technologies (Psilocybin Alpha)

• Why Bristol Uni is taking a more progressive stance on drugs (The Bristol Cable)

• Numinus Completes Acquisition of Neurology Centre of Toronto (Psilocybin Alpha)

• The Removal of the Ecuadorian Drug Possession Table: A Major Government Mistake (TalkingDrugs)

• ATMA Journey Centers Offer Regulated Health Care Professionals a Means to Incorporate Psychedelic-Assisted Psychotherapy Into Their Practice (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 5.28.21

Cannabis

• New York bans delta-8 THC, resists calls to track hemp like marijuana (Marijuana Business Daily)

• Legal Marijuana States Have Generated Nearly $8 Billion In Tax Revenue Since Recreational Sales Launched, Report Finds (Marijuana Moment)

• Minnesota: Governor Signs Legislation into Law to Legalize Medical Marijuana Flower (NORML)

• Nevada: Lawmakers Send Multiple Marijuana Reform Measures to Governor’s Desk (NORML)

• Cannabis emoji remains elusive: When it will exist, what it might look like, and why we don’t have one (yet) (GreenState)

• Louisiana: House-Approved Marijuana Decriminalization Bill Heads to Senate Floor (NORML)

• The Decriminalization of Marijuana in Brazil Beyond the Medicinal Use: Cannabis Associations and Human Rights (Chacruna)

• Atheists Are Much More Likely To Back Marijuana Legalization Than Christians Are, New Poll Finds (Marijuana Moment)

LSD

• Microdosing Psilocybin and LSD: Panacea or Placebo? (Spirit Pharmacist)

• MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing (Psilocybin Alpha)

Magic Mushrooms

• Attorneys General Back Doctor on DEA Psilocybin Lawsuit (Truffle Report)

• Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms (Psilocybin Alpha)

• María Sabina, Mushrooms, and Colonial Extractivism (Chacruna)

• The Psilocybin vs. Escitalopram Trial – Part 1 (Psychedelic Science Review)

MDMA

• The Effects of MDMA on Liver Health (Truffle Report)

DMT

• Algernon Pharmaceuticals Highlights New Animal Study Showing Effectiveness of Psychedelic Drug DMT in Treatment of Stroke (Psilocybin Alpha)

Ayahuasca

• When Ayahuasca Microdosing Might Cause Serotonin Toxicity (Chacruna)

• Breathe Easy: Combining Albuterol & Ayahuasca (Spirit Pharmacist)

Iboga

• Why Iboga Is Considered a Master Healer (Lucid News)

Novel Psychoactive Substances

• Non-hallucinogenic psychedelic analog reverses effects of stress in mouse study (Science Daily)

Nitrous Oxide

• London borough bans ‘laughing gas’ nitrous oxide over anti-social behaviour (The Independent)

Ketamine

• Effort to limit ketamine use by Colorado paramedics, police advances toward governor’s desk (The Colorado Sun)

• PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig’s Disease (Psilocybin Alpha)

• PharmaTher Collaborates with MediSynergics to Develop Patented Ketamine Formulation for Pain Disorders and to Discover Novel Psychedelic Formulations (Psilocybin Alpha)

Miscellaneous

• Texas Senate Approves Psychedelics And Marijuana Concentrates Bills (Marijuana Moment)

• Maine Lawmakers Advance Drug Decriminalization Bill To House Floor With Conflicting Recommendations (Marijuana Moment)

• Psychedelics’ Exciting Potential to Benefit Autistic People (Filter)

• Virtual Reality and Psychedelic Synergy (Psychedelic Science Review)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 9.25.20

Cannabis

• Vermont Bills To Legalize Marijuana Sales And Expunge Convictions Head To Governor’s Desk (Marijuana Moment)

• Barbados Is Inches Away From Decriminalizing Cannabis Possession (MERRY JANE)

• Delta-8-THC Promises to Get You High Without the Paranoia or Anxiety (Discover Magazine)

• New Marijuana Coalition Unveils Plan To Legalize Interstate Cannabis Commerce (Marijuana Moment)

• ‘Failure’ to embrace medical cannabis has caused “preventable deaths” – report (Cannabis Health News)

• Using weed during pregnancy linked to psychotic-like behaviors in children, study finds (CNN)

• Texas Ban On Smokable Hemp Lifted Until 2021, Judge Rules (Marijuana Moment)

• Playboy Gets Serious About Cannabis Law Reform Advocacy With New Partnership, Grants (Forbes)

• Study: Use of Cannabis Long-Term Not Associated with Cognitive Differences in Older Adults (NORML)

• FDA Explains Effects Of CBD And Marijuana Compounds Based On Sex And Gender Differences (Marijuana Moment)

• Survey: Nearly One in Three Migraine Sufferers Have Used Cannabis for Symptom Management, Most Report It to Be Effective (NORML)

• South Dakota Voters Support Medical And Recreational Marijuana Initiatives, New Opposition Poll Finds (Marijuana Moment)

Magic Mushrooms

• Oregon Democratic Party Endorses Legal Psilocybin Therapy And Drug Decriminalization Ballot Measures (Marijuana Moment)

• MindMed and Liechti Lab Announce R&D Collaboration On Psilocybin (PR Newswire)

• Inside 9/20, the Holiday for Psychedelic Mushrooms (Rolling Stone)

MDMA

• Ecstasy use down during pandemic; Psychedelics draw more interest (NL Times)

Ayahuasca

• Tribute to Dr. Domingos Bernardo, the Legal Expert who Fought for the Liberation of Ayahuasca in Brazil (1941-2020) (Chacruna)

Novel Psychoactive Substances

• Mindset Pharma Reports Positive Results of Synthetic Psilocybin-Inspired Compounds (Lucid News)

Ketamine

• This Wearable Ketamine Device Could Be The Future Of Pain Management (Forbes)

Miscellaneous

• Ann Arbor Decriminalizes Psychedelics (DoubleBlind)

• COMPASS Pathways Closes $147 million IPO (Psilocybin Alpha)

• President Behind Mexico’s War on Drugs Admitted It Was ‘Unwinnable’ (VICE)

• The Legal Response to Breonna Taylor's Death Shows How Drug Prohibition Transforms Murder Into Self-Defense (Reason)

• Who Will Benefit From Psychedelic Medicine? (The Washington Post)

• Mind Cure Becomes Latest Publicly-Traded Psychedelic Company (Psilocybin Alpha)

• 60 Percent of DC Voters Support Plant Medicine Decriminalization (Lucid News)

• MindMed Applies to List on Nasdaq (Psilocybin Alpha)

• Can Psychedelics Rekindle Ancient Animism in Modern Society? (DoubleBlind)

• Meet the ‘psychedelic concierge’ to the stars (Page Six)

• Why Psychedelic Therapy is Effective at Combating Addiction (Sam Woolfe)

• Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration (Psilocybin Alpha)

• Dr. Michael Mithoefer & Ann Mithoefer from MAPS Join AWAKN's Scientific Board (Stockhouse)

• The Psychedelic Election is an Internet Addiction (Lucid News)

• An Interview with Mariavittoria Mangini (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.